Fredun Pharmaceuticals Limited (BOM:539730)

Fredun Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 20, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	6,973	3,142	3,371	3,572	4,057	1,849
Market Cap Growth	103.12%	-6.80%	-5.63%	-11.97%	119.38%	297.73%
Enterprise Value	8,596	4,496	3,993	4,419	4,511	2,181
Last Close Price	1476.80	668.17	716.23	775.47	912.61	461.51
PE Ratio	24.90	15.92	21.58	33.05	64.04	91.80
PS Ratio	1.31	0.69	0.97	1.30	1.81	1.38
PB Ratio	4.43	2.22	2.78	3.71	5.96	4.29
P/TBV Ratio	4.45	2.23	2.79	3.72	5.97	4.30
P/FCF Ratio	40.47	-	-	-	-	-
P/OCF Ratio	19.36	-	-	-	-	1088.52
EV/Sales Ratio	1.62	0.99	1.15	1.61	2.01	1.63
EV/EBITDA Ratio	12.95	8.38	10.50	15.82	32.51	23.72
EV/EBIT Ratio	14.26	9.23	11.64	17.56	38.42	30.24
EV/FCF Ratio	49.89	-	-	-	-	-
Debt / Equity Ratio	1.09	1.19	0.87	0.90	0.89	1.06
Debt / EBITDA Ratio	2.58	3.14	2.77	3.10	4.37	4.99
Debt / FCF Ratio	9.93	-	-	-	-	-
Asset Turnover	1.30	1.14	1.23	1.24	1.29	0.88
Inventory Turnover	2.02	1.69	1.70	2.23	3.23	1.81
Quick Ratio	0.28	0.56	0.40	0.27	1.25	0.49
Current Ratio	1.44	1.30	1.54	1.55	2.07	1.51
Return on Equity (ROE)	19.11%	15.02%	14.34%	13.14%	11.40%	4.78%
Return on Assets (ROA)	9.19%	7.66%	7.59%	7.08%	4.21%	2.97%
Return on Invested Capital (ROIC)	14.76%	13.23%	12.35%	10.15%	8.07%	5.47%
Return on Capital Employed (ROCE)	30.80%	30.60%	24.40%	21.40%	10.40%	9.60%
Earnings Yield	3.95%	6.28%	4.63%	3.03%	1.56%	1.09%
FCF Yield	2.47%	-11.20%	-2.40%	-6.69%	-1.64%	-0.66%
Dividend Yield	0.05%	0.10%	0.10%	0.09%	0.08%	0.15%
Buyback Yield / Dilution	0.49%	-	-3.66%	-7.85%	-4.06%	-0.01%
Total Shareholder Return	0.53%	0.10%	-3.56%	-7.76%	-3.98%	0.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.